Bicycle Therapeutics (BCYC) Share-based Compensation (2018 - 2025)
Historic Share-based Compensation for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $8.8 million.
- Bicycle Therapeutics' Share-based Compensation fell 468.38% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 726.66%. This contributed to the annual value of $38.1 million for FY2024, which is 1725.53% up from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Share-based Compensation is $8.8 million, which was down 468.38% from $9.4 million recorded in Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' Share-based Compensation peaked at $10.3 million during Q4 2024, and registered a low of $2.6 million during Q2 2021.
- In the last 5 years, Bicycle Therapeutics' Share-based Compensation had a median value of $8.2 million in 2023 and averaged $7.2 million.
- In the last 5 years, Bicycle Therapeutics' Share-based Compensation soared by 16689.35% in 2022 and then crashed by 1133.56% in 2023.
- Over the past 5 years, Bicycle Therapeutics' Share-based Compensation (Quarter) stood at $3.0 million in 2021, then skyrocketed by 84.73% to $5.5 million in 2022, then surged by 41.01% to $7.8 million in 2023, then skyrocketed by 32.27% to $10.3 million in 2024, then decreased by 15.12% to $8.8 million in 2025.
- Its Share-based Compensation was $8.8 million in Q3 2025, compared to $9.4 million in Q2 2025 and $9.6 million in Q1 2025.